Xencor (XNCR)
(Delayed Data from NSDQ)
$21.07 USD
-0.13 (-0.61%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $21.07 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Xencor, Inc. [XNCR]
Reports for Purchase
Showing records 101 - 120 ( 221 total )
Company: Xencor, Inc.
Industry: Medical - Drugs
From Underneath The Rubble Sing a Rebel Song
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Partnered Program Developments Show Off XNCR?s Licensing Strategy
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Antibody Cadillac Escalates...Through Multiple Doses
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Xencor, Inc.
Industry: Medical - Drugs
1Q19 Financials; Multiple Clinical Milestones Expected 2H19
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Xencor, Inc.
Industry: Medical - Drugs
XNCR Oncology Assets Move Forward, Obexelimab Looking For a Partner
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Immuno-Oncology Pipeline, Cash Balance, Grows with Genentech Collaboration
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D